Search

for
Search:

Research

5 / 1000+ results

LB1139 AMP-303 Injectable Treatment for Androgenetic Alopecia: A Multicenter, Randomized, Placebo-Controlled Feasibility Study of a Novel Polysaccharide

research LB1139 AMP-303 injectable treatment for androgenetic alopecia: A multicenter, randomized, placebo-controlled feasibility study of a novel polysaccharide

July 2025 in “Journal of Investigative Dermatology”

In this study, AMP-303 injections demonstrated a trend toward increasing non-vellus hair count in men with mild to moderate androgenetic alopecia, notably showing a 14.5% peak increase at 60 days compared to saline, with effects lasting up to five months.

research 453 Signaling by Senescent Melanocytes Induces New Hair Growth and Informs Hair Growth-Activating Injectable for Androgenetic Alopecia

November 2025 in “Journal of Investigative Dermatology”

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

research Emerging pharmacotherapies for Androgenetic Alopecia

June 2026 in “Expert Opinion on Pharmacotherapy”

This article reviews emerging therapies for androgenetic alopecia, highlighting advances like androgen-receptor antagonists and improved minoxidil delivery that aim to enhance treatment efficacy and safety.

research Association of premature hair graying with family history, smoking, and obesity: A cross-sectional study

46 citations , December 2014 in “Journal of The American Academy of Dermatology”

This study found that smoking, obesity, and family history are significant risk factors for premature hair graying in young men.

research A Screening Study on Dermatoses in Pregnancy

9 citations , January 2017 in “Journal of Clinical and Diagnostic Research”

This article reviews the skin changes during pregnancy, categorizing them by their relation to pregnancy and highlighting cosmetic concerns, but reports no new results.

View more "amp-303" in research →

Community Join

5 / 93 results

community New Hair Loss Cure: AMP-303 Is Back. It’s what PP405 should have been.

7 upvotes 5 months ago

AMP-303 and AMP-601 are new hair loss treatments targeting dermal papilla cells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.

community Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments

in Treatment 39 upvotes 1 year ago

AMP-303, a new injectable treatment for androgenetic alopecia, showed promising results in increasing hair count and density with minimal side effects. The treatment demonstrated significant hair regrowth and durability, offering new hope for those with hair loss.